Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 27, 2024 · Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly-owned and independently operated as a subsidiary of Bayer, has announced a new strategic collaboration with Belief BioMed (BBM) to explore the potential for new gene therapies. 25 September 2024. Italian biotech Genespire—which is developing off-the-shelf gene therapies for ...
Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >.
Pharmaceutical Generics Industry News | The Pharmaletter
WEBSep 2, 2024 · Glenmark pays $25 million fine for generic price-fixing. Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024.
Login - The Pharmaletter
WEB2 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
About The Pharma Letter | The Pharmaletter
WEB6 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Subscribe to The Pharma Letter | The Pharmaletter
WEB4 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
EMA drug regulation and approval news | The Pharmaletter
WEBSep 21, 2024 · EC approval for Moderna’s RSV vaccine mRESVIA. Moderna today received approval from the European Commission (EC) for its mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. 23 August 2024.
Biotech Industry News | The Pharmaletter
WEBSep 17, 2024 · Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly-owned and independently operated as a subsidiary of Bayer, has announced a new strategic collaboration with Belief BioMed (BBM) to explore the potential for new gene therapies. 25 September 2024. Bristol Myers Squibb has scored a major legal victory as a judge in New York ...
Pharma M&A news | The Pharmaletter
WEBSep 18, 2024 · Fosun Pharma secures full ownership of Fosun Kite with $27 million deal. Shanghai-based Fosun Pharmaceutical has announced it has acquired the remaining 50% stake in Fosun Kite Biotechnology from Kite Pharma for $27 million, giving it full control of the joint venture. 23 September 2024. Pharmaceutical.
Neurological - The Pharmaletter
WEBSep 27, 2024 · Nxera Pharma’s Quviviq approved in Japan for insomnia. Japan’s Ministry of Health, Labor and Welfare of Japan (MHLW) has approved New Drug Application (NDA) for Quviviq (daridorexant; ACT-541468) 25mg and 50mg for the treatment of adult patients with insomnia, submitted by Nxera Pharma. 24 September 2024.